Literature DB >> 1549907

Well-differentiated thymic carcinoma: a clinico-pathological study.

E Pescarmona1, S Rosati, E A Rendina, F Venuta, C D Baroni.   

Abstract

Well-differentiated thymic carcinoma (WDTC) is a recently described epithelial tumour of the thymus previously classified as cortical or predominantly epithelial thymoma. The authors have reviewed a series of 15 cases of WDTC with the aim of further defining the clinicopathological features of this neoplasm. Histologically, the number of lymphocytes was always low; perivascular spaces and epithelial palisading around blood vessels and/or along fibrous septa were prominent features; 6 cases (40%) were associated with areas of typical cortical thymoma. All cases showed slight to moderate cytological atypia and nuclear grooving was frequently detected. Mitotic activity was variable but usually low. Clinically, all but 3 cases (80%) were invasive at surgery; myasthenia gravis was present in 9 cases (60%); 5 patients (33.3%) died due to disease and 2 additional patients (13.3%) had tumor recurrence. Our study indicates that WDTC has fairly distinctive clinicopathological features and that it is histologically and histogenetically related to cortical thymoma. The definition "well-differentiated carcinoma" is justified because of low-grade cytological atypia and retention of some organotypical histological features, in a tumour otherwise often displaying aggressive and sometimes clear-cut malignant clinical behaviour.

Entities:  

Mesh:

Year:  1992        PMID: 1549907     DOI: 10.1007/bf02358810

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  8 in total

1.  Thymic hyperplasia and neoplasia: a review of current concepts.

Authors:  G D Levine; J Rosai
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

2.  Thymic carcinoma. A clinicopathologic study of 13 cases.

Authors:  L D Truong; D R Mody; P T Cagle; G L Jackson-York; M R Schwartz; T M Wheeler
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

3.  Thymic carcinomas: histopathological varieties and immunohistochemical study.

Authors:  T T Kuo; J P Chang; F J Lin; W C Wu; C H Chang
Journal:  Am J Surg Pathol       Date:  1990-01       Impact factor: 6.394

4.  Multiple thymic squamous cell carcinomas associated with mixed type thymoma.

Authors:  S Morinaga; Y Sato; Y Shimosato; T Sinkai; R Tsuchiya
Journal:  Am J Surg Pathol       Date:  1987-12       Impact factor: 6.394

5.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Correlations between histological type, clinical behaviour, and prognosis in thymoma.

Authors:  C Ricci; E A Rendina; E O Pescarmona; F Venuta; R Di Tolla; L P Ruco; C D Baroni
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

7.  The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases.

Authors:  E Pescarmona; E A Rendina; F Venuta; C Ricci; L P Ruco; C D Baroni
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

8.  Thymic carcinoma. Five distinctive histological variants.

Authors:  D C Snover; G D Levine; J Rosai
Journal:  Am J Surg Pathol       Date:  1982-07       Impact factor: 6.394

  8 in total
  3 in total

1.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  Prognostic factors of patients with thymoma.

Authors:  W S Lee; D S Heo; Y J Bang; K S Lee; J S Ahn; C W Jung; S K Han; S W Sung; J H Kim; Y S Shim; C I Park; N K Kim
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.